APA

Kelly O. B., Donnell S. O., Stempak J. M., Steinhart A. H. & Silverberg M. S. (20180424). Therapeutic Drug Monitoring to Guide Infliximab Dose Adjustment is Associated with Better Endoscopic Outcomes than Clinical Decision Making Alone in Active Inflammatory Bowel Disease. : Inflammatory bowel diseases.

Chicago

Kelly Orlaith B, Donnell Sarah Oʼ, Stempak Joanne M, Steinhart A Hillary and Silverberg Mark S. 20180424. Therapeutic Drug Monitoring to Guide Infliximab Dose Adjustment is Associated with Better Endoscopic Outcomes than Clinical Decision Making Alone in Active Inflammatory Bowel Disease. : Inflammatory bowel diseases.

Harvard

Kelly O. B., Donnell S. O., Stempak J. M., Steinhart A. H. and Silverberg M. S. (20180424). Therapeutic Drug Monitoring to Guide Infliximab Dose Adjustment is Associated with Better Endoscopic Outcomes than Clinical Decision Making Alone in Active Inflammatory Bowel Disease. : Inflammatory bowel diseases.

MLA

Kelly Orlaith B, Donnell Sarah Oʼ, Stempak Joanne M, Steinhart A Hillary and Silverberg Mark S. Therapeutic Drug Monitoring to Guide Infliximab Dose Adjustment is Associated with Better Endoscopic Outcomes than Clinical Decision Making Alone in Active Inflammatory Bowel Disease. : Inflammatory bowel diseases. 20180424.